Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Inhibitor-Based Therapies for Thyroid Cancer—An Update
Maciej Ratajczak, Damian Gaweł, Marlena Godlewska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11829-11829
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect
Linnea Højer Wang, Markus Wehland, Petra M. Wise, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2312-2312
Open Access | Times Cited: 22
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 34
Molecular features of aggressive thyroid cancer
Giusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 23
State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer
Horațiu Silaghi, Vera Lozovanu, Carmen Emanuela Georgescu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3470-3470
Open Access | Times Cited: 20
NTRK fusions in thyroid cancer: Pathology and clinical aspects
Yanhui Ma, Qi Zhang, Kexin Zhang, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 184, pp. 103957-103957
Closed Access | Times Cited: 9
Cyanidin as potential anticancer agent targeting various proliferative pathways
Muhammad Azhaf Safdar, Rana Muhammad Nabeel Aslam, Amna Shakeel, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 2, pp. 438-452
Closed Access | Times Cited: 14
Acetate-Mediated Odorant Receptor OR51E2 Activation Results in Calcitonin Secretion in Parafollicular C-Cells: A Novel Diagnostic Target of Human Medullary Thyroid Cancer
Hyeon Jeong Lee, Cheol Ryong Ku, Arthur Cho, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1688-1688
Open Access | Times Cited: 8
Clinicopathological and Genetic Characteristics of Patients of Different Ages with Diffuse Sclerosing Variant Papillary Thyroid Carcinoma
Soo Young Kim, Su‐Jin Shin, Dong‐Gi Lee, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3101-3101
Open Access | Times Cited: 7
Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street
Ioana Balinisteanu, Monica-Cristina Pânzaru, Lavinia Caba, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2143-2143
Open Access | Times Cited: 7
Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
Laurys Boudin, J.-B. Morvan, Juliette Thariat, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7718-7731
Open Access | Times Cited: 11
Cancer gene analysis of liquid‐based cytology specimens using next‐generation sequencing: A technical report of bimodal DNA‐ and RNA‐based panel application
Toshiaki Akahane, Tomomi Isochi‐Yamaguchi, Natumi Hashiba‐Ohnuki, et al.
Diagnostic Cytopathology (2023) Vol. 51, Iss. 8, pp. 493-500
Closed Access | Times Cited: 6
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies
Giusy Elia, Silvia Martina Ferrari, Francesca Ragusa, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 5, pp. 599-610
Closed Access | Times Cited: 9
Predictive Biomarkers in Thyroid Cancer
Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Acute exposure to diesel particulate matter promotes collective cell migration in thyroid cancer cells
Sheena Yi-Hsin Cheng, Shih-Yuan Huang, Shih‐Ping Cheng
Frontiers in Toxicology (2023) Vol. 5
Open Access | Times Cited: 5
Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells
Koichi Ohno, Tomohiro Shibata, Ken‐ichi Ito
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3193-3210
Open Access | Times Cited: 8
HLA-G Gene Variability Is Associated with Papillary Thyroid Carcinoma Morbidity and the HLA-G Protein Profile
Bruna C. Bertol, Guilherme Debortoli, Fabrício C. Dias, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12858-12858
Open Access | Times Cited: 4
GNA15 facilitates the malignant development of thyroid carcinoma cells via the BTK-mediated MAPK signaling pathway.
Yihan Sun, Yifan Han
PubMed (2024) Vol. 39, Iss. 9, pp. 1217-1227
Closed Access | Times Cited: 1
Expression of pY397-FAK and Its miR Regulators Drive Dedifferentiation in the Thyroid Neoplasia Spectrum
Valentina Ignjatović Jocić, Jelena Janković, Tijana Išić Denčić, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1721-1721
Open Access | Times Cited: 3
The Incidence Trend and Management of Thyroid Cancer—What Has Changed in the Past Years: Own Experience and Literature Review
Krzysztof Kaliszewski, Dorota Diakowska, Michał Miciak, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4941-4941
Open Access | Times Cited: 3
Drug-induced inhibition of HMGA and EZH2 activity as a possible therapy for anaplastic thyroid carcinoma
Marco De Martino, Simona Pellecchia, Myriam Decaussin‐Petrucci, et al.
Cell Cycle (2023) Vol. 22, Iss. 23-24, pp. 2552-2565
Closed Access | Times Cited: 3
The Difference in Clinical Behavior of Gene Fusions Involving RET/PTC Fusions and THADA/IGF2BP3 Fusions in Thyroid Nodules
George Tali, Alexandra E. Payne, Thomas J. Hudson, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3394-3394
Open Access | Times Cited: 2
Identification of Circulating Exosomal microRNAs Associated with Radioiodine Refractory in Papillary Thyroid Carcinoma
Genpeng Li, Wenjie Chen, Yanping Gong, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 2017-2017
Open Access | Times Cited: 4
Analysis of the Rehabilitation Efficacy and Nutritional Status of Patients After Endoscopic Radical Thyroidectomy by Fast Track Surgery Based on Nutritional Support
Qu Fang, Hongxia Bu, Yang Liu, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 3
Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
Jing Li, Yingjie Zhang, Fenghao Sun, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 3
Papillary Thyroid Cancer Remodels the Genetic Information Processing Pathways
Dumitru A. Iacobaş, Sanda Iacobaş
Genes (2024) Vol. 15, Iss. 5, pp. 621-621
Open Access
Page 1 - Next Page

Scroll to top